Immune-globulin

  • PDF / 168,896 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 88 Downloads / 160 Views

DOWNLOAD

REPORT

1 S

Anaphylaxis and thrombosis: 2 case reports In a retrospective, observational study of 49 patients, conducted between January 2010 and July 2018, two patients [ages and sexes not stated] were described; who received treatment with IV immune-globulin [IVIg] for chronic inflammatory demyelinating polyneuropathy. However, the patients developed anaphylaxis (n=1) and thrombosis (n=1). Both the patients required inpatient treatment [dosage, duration of treatment to reaction onsets and outcomes not stated]. Terhoeven P, et al. Longer-term effects of intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: Who benefits?. Journal of the 803517555 Neurological Sciences 419: 117169, 15 Dec 2020. Available from: URL: http://doi.org/10.1016/j.jns.2020.117169

0114-9954/20/1832-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

Reactions 28 Nov 2020 No. 1832

Data Loading...